Age at Diagnosis of Myeloproliferative Neoplasm Affects Pattern of Thrombotic Events but Not Mortality Risk

Results from a recent multicenter retrospective study of patients ages 18 to 45 with Philadelphia chromosome–negative MPNs showed that the risks of mortality and MF/leukemia progression among this age group were similar to that of older adults with MPNs.

Oncology Nurse Advisor